home / stock / impl / impl quote
Last: | $0.2411 |
---|---|
Change Percent: | -2.03% |
Open: | $0.4226 |
Close: | $0.2411 |
High: | $0.44 |
Low: | $0.2285 |
Volume: | 638,446 |
Last Trade Date Time: | 12/15/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.2411 | $0.4226 | $0.2411 | $0.44 | $0.2285 | 638,446 | 12-15-2023 |
$0.4142 | $0.41 | $0.4142 | $0.449699 | $0.38 | 90,473 | 12-14-2023 |
$0.3761 | $0.38 | $0.3761 | $0.4281 | $0.360001 | 126,759 | 12-13-2023 |
$0.3602 | $0.4161 | $0.3602 | $0.4161 | $0.36 | 79,307 | 12-12-2023 |
$0.3503 | $0.405 | $0.3503 | $0.405 | $0.35 | 164,867 | 12-11-2023 |
$0.41 | $0.4114 | $0.41 | $0.445 | $0.3882 | 144,056 | 12-08-2023 |
$0.43 | $0.42 | $0.43 | $0.46 | $0.41 | 109,936 | 12-07-2023 |
$0.4179 | $0.4666 | $0.4179 | $0.4784 | $0.4101 | 247,006 | 12-06-2023 |
$0.466 | $0.441 | $0.466 | $0.528 | $0.441 | 491,212 | 12-05-2023 |
$0.4534 | $0.385 | $0.4534 | $0.5407 | $0.3801 | 1,178,525 | 12-04-2023 |
$0.3693 | $0.4095 | $0.3693 | $0.42 | $0.35 | 398,781 | 12-01-2023 |
$0.4195 | $0.45 | $0.4195 | $0.5001 | $0.41 | 586,077 | 11-30-2023 |
$0.5212 | $0.6444 | $0.5212 | $0.6444 | $0.51 | 672,897 | 11-29-2023 |
$0.598 | $0.6453 | $0.598 | $0.699 | $0.5301 | 1,189,026 | 11-28-2023 |
$0.5994 | $0.63 | $0.5994 | $0.8 | $0.5684 | 2,213,706 | 11-27-2023 |
$0.8445 | $0.58 | $0.8445 | $0.95 | $0.5005 | 7,598,455 | 11-24-2023 |
$0.779 | $0.3356 | $0.779 | $1.06 | $0.3204 | 27,136,102 | 11-23-2023 |
$0.779 | $0.3356 | $0.779 | $1.06 | $0.3204 | 27,136,102 | 11-22-2023 |
$0.32 | $0.3006 | $0.32 | $0.35 | $0.3006 | 197,565 | 11-21-2023 |
$0.3021 | $0.2972 | $0.3021 | $0.3061 | $0.2553 | 370,971 | 11-20-2023 |
News, Short Squeeze, Breakout and More Instantly...
Impel Pharmaceuticals Inc. Company Name:
IMPL Stock Symbol:
NASDAQ Market:
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Impel Pharmaceuticals Inc. (IMPL) is expected to report for Q3 2023
2023-10-05 09:39:40 ET DENVER, Colo., Oct 5, 2023 ( www.247marketnews.com )- Impel Pharmaceuticals Inc. (NASDAQ: IMPL) stated, this morning, that it is exploring strategic alternatives and plans to consider a wide range of options with a focus on maximizing shareholder value, including ...